Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergsk.com
Press releases
Get the latest updates from Press releases directly as they happen.
Follow now 506 followers
Latest posts
Last updated 1 day ago
GLISTEN phase III trial results show linerixibat significantly improves cholestatic pruritus (relentless itch) in primary biliary cholangitis (PBC)
1 day ago
Late-breaking results presented at the European Association for the Study of the...
GSK continues to advance the future of respiratory medicine and patient care with new data at ATS
7 days ago
40+ abstracts across GSK’s inhaled and respiratory biologics portfolio
Nucala (mepolizumab) delivers clinically meaningful and statistically significant reduction in COPD exacerbations, with positive MATINEE trial results published in New England Journal of Medicine
9 days ago
21% reduction in annualised rate of moderate/severe exacerbations in a wide COPD...
GSK makes strong start to 2025 with growth in sales, profits and earnings
9 days ago
Q1 2025 performance highlights
Blenrep (belantamab mafodotin) combinations approved by UK MHRA in relapsed/refractory multiple myeloma
22 days ago
Superior efficacy shown in two head-to-head phase III trials, including overall survival...
GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices
23 days ago
Vaccine recommended to help protect persons over 10 years old in the...
Arexvy recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices
23 days ago
Over 13 million adults aged 50-59 at increased risk in the US...
Blujepa (gepotidacin) approved by US FDA for treatment of uncomplicated urinary tract infections (uUTIs) in female adults and paediatric patients 12 years of age and older
about 1 month ago
Blujepa is the first in a new class of oral antibiotics for...
GSK, UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to collaborate on first-of-its-kind dementia research initiative
about 1 month ago
New collaboration aims to deepen understanding of neurodegeneration using the UK’s unique...
GSK’s application to expand use of Nucala (mepolizumab) for the treatment of COPD accepted for review by the European Medicines Agency
about 2 months ago
Nucala (mepolizumab) could be the first biologic with monthly dosing for patients...
ViiV Healthcare’s investigational broadly neutralising antibody - N6LS - successfully maintains viral suppression in long-acting treatment of HIV
about 2 months ago
Results from the study demonstrate that N6LS effectively maintained undetectable viral load...
ViiV Healthcare announces new implementation study data showing zero cases of HIV with Apretude, the only long-acting injectable approved for HIV PrEP
about 2 months ago
New data at CROI 2025 show zero cases of HIV acquisition reported...